Search Results for: us stem cell

Report: CIRM creates 8 jobs a day for California

A report will be issued today of the economic impact of CIRM on California. The Sac Bee and FierceBiotech are reporting on the economic infusion that CIRM has provided to the state. On average during its existence, CIRM has created 8 jobs day for the state of California. The jobs mostly consist not surprisingly of …

Report: CIRM creates 8 jobs a day for California Read More »

My Cancer: how I became an advocate too

IMG_0572

There is a kind of invisible cultural wall between patients such as cancer patients and biomedical scientists like me, but this wall does not have to exist and indeed it is a negative wall as patients, scientists, doctors, agencies, and advocates can achieve far more together than apart. But the wall is surprisingly strong. Last …

My Cancer: how I became an advocate too Read More »

Scientific-proof for the DC Court of Appeals that life begins at conception? Not by a long shot

The DC Appeals Court hears oral arguments today in the case over whether the federal government can legally fund embryonic stem cell (ESC) research. At stake are dozens of research projects that could provide treatments or cures for millions of Americans. Reportedly, an amicus brief to the court has been filed on behalf of Associate …

Scientific-proof for the DC Court of Appeals that life begins at conception? Not by a long shot Read More »

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness

advanced-cell-technology

The FDA has given Advanced Cell Technology (ACT) the go ahead to begin their clinical trial using retinal progenitor cells derived from hESC by clearing the company’s IND application, bringing hope to those with vision loss and even blindness. The trial will be a combined Phase I/II to treat Stargardt’s Macular Dystrophy and has huge …

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness Read More »

How many scientist bloggers does it take to change a light bulb?

Stem-Cell-Blog

One question I am frequently asked by readers and colleagues is “what other stem cell blogs or bloggers can you recommend that are written by a stem cell scientist and updated on a regular basis?” The simple but surprising answer: there are none. It’s lonely out here in cyberspace! (2020 update: The good news today …

How many scientist bloggers does it take to change a light bulb? Read More »

James Sherley of anti-ESC lawsuit calls on NIH to think like he does

James-Sherley

Dr. James Sherley, the scientist behind the lawsuit against federally-funded ES cell research, has penned an opinion piece in The Daily Caller today calling on NIH to, in his words, ‘do the right thing.’ However, what Sherley is really asking is for the NIH, other stem cell scientists, and all Americans to think like he …

James Sherley of anti-ESC lawsuit calls on NIH to think like he does Read More »

Huntington’s Disease, a major new finding

Huntingtons-Disease

This is the first post in a series focusing on stem cell advances related to specific diseases. Today we discuss Huntington’s Disease and a paper that came out yesterday in the journal Neuron that provides some significant insight into the mechanisms behind the disease. It is entitled: Huntingtin Is Required for Mitotic Spindle Orientation and …

Huntington’s Disease, a major new finding Read More »

I Hate Your Paper: Dr. No and the Editors that are ruining peer review

Dr.-No-peer-review

Update: Now in 2020 it seems that peer review remains very problematic. The Scientist has a few pieces out on the trouble with peer review including my personal favorite: I Hate Your Paper. That article rings so true as do the quotes from the scientists. Peer review in the stem cell field and the IPS cell …

I Hate Your Paper: Dr. No and the Editors that are ruining peer review Read More »

Tumorigenicity and Pluripotency teased apart? Not yet for Myc

Fig.-5-Nakagawa-et-al.-Myc-in-cancer-and-IPScs

A paper just came out in PNAS entitled “Promotion of direct reprogramming by transformation-deficient Myc“. The main thrust of this paper is that the tumorigenic and pluripotency-related functions of Myc could be separated. It focused primarily on the lesser studied LMyc. The topic of the intertwined good (pluripotency) and bad (tumorigenicity) functions of Myc, addressed …

Tumorigenicity and Pluripotency teased apart? Not yet for Myc Read More »